2026 NPPES data Clinical Genetics (M.D.) Physician NPI 1265066252 MD
Verify on CMS →

Tuncay Delibasi, MD

Clinical Genetics (M.D.) Physician in Syracuse, New York. This profile is drawn from the federal National Provider Identifier Registry (CMS NPPES), which lists more than 7 million U.S. healthcare providers - including 825 in Clinical Genetics (M.D.) Physician, and covers specialty classification, practice address, and Medicare Part D prescribing data when reported. According to CMS, every field reflects the provider's official federal registration, see our methodology.

Federal data, no proprietary rating. We show these CMS records as-is - no composite score, no star rating, no editorial opinion layered on top.
Prescribing volume
500
Medicare Part D claims · 153 beneficiaries · Clinical Genetics (M.D.) Physician avg: 261
Generic prescribing
49%
generic claims · 40% brand-name · higher generic rates reduce patient out-of-pocket costs
MIPS score
81.6/100
▼ 1 pts below national avg 83.1 · Above neutral
Industry payments
$134.37
1 payments · CMS Open Payments (Sunshine Act)
Compiled from official public sources by the PlainDoctor editorial team.

What the federal data shows

Tuncay Delibasi, MD reported a CMS MIPS final score of 81.6/100 - below the 83.1 national average - and filed 500 Medicare Part D claims in 2023.

81.6/100
MIPS score · -1 vs avg
500
Part D claims, 2023
49%
generic prescribing
Likely
board-certified (heuristic)

Every figure on this page comes straight from federal CMS records (NPPES, Medicare Part D, MIPS, Open Payments) - no proprietary rating or editorial opinion is applied.

Tuncay Delibasi, MD's MIPS score vs every scored U.S. clinician

CMS Merit-based Incentive Payment System (MIPS) final score, 2023, the federal quality measure

82 36th percentile higher than 36% of 477,587 scored providers

0–10: 8,684 scored providers (2%). Below this entry. 10–20: 3,008 scored providers (1%). Below this entry. 20–30: 3,069 scored providers (1%). Below this entry. 30–40: 2,746 scored providers (1%). Below this entry. 40–50: 2,928 scored providers (1%). Below this entry. 50–60: 5,882 scored providers (1%). Below this entry. 60–70: 13,906 scored providers (3%). Below this entry. 70–80: 118,074 scored providers (25%). Below this entry. 80–90: 129,887 scored providers (27%). This entry sits in this band. 90+: 189,403 scored providers (40%). Above this entry. This provider 0 100 every MIPS-scored clinician, bucketed by value

Each bar is a band; taller bars hold more scored providers. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source CMS Merit-based Incentive Payment System (MIPS) · 2023

Where Tuncay Delibasi, MD sits

This provider among clinical genetics (m.d.) physician peers

Across the 47 clinical genetics (m.d.) physician providers who report both Medicare Part D prescribing and a MIPS quality score, Tuncay Delibasi, MD writes more Part D claims than 91% of them and scores higher on MIPS quality than 38% - placing this provider in the high-volume, lower-quality quadrant. Volume reflects patient-panel size and specialty, not quality; the two axes are independent.

Part D claim volume vs MIPS quality, by specialty percentile

Lower volume · High qualityHigh volume · High qualityLower volume · Lower qualityHigh volume · Lower quality02550751000255075100Part D claim volume, percentile in specialtyMIPS quality, percentilePart D claim volume, percentile in specialty: 26 · MIPS quality, percentile: 7Part D claim volume, percentile in specialty: 9 · MIPS quality, percentile: 78Part D claim volume, percentile in specialty: 33 · MIPS quality, percentile: 46Part D claim volume, percentile in specialty: 74 · MIPS quality, percentile: 13Part D claim volume, percentile in specialty: 61 · MIPS quality, percentile: 33Part D claim volume, percentile in specialty: 37 · MIPS quality, percentile: 91Part D claim volume, percentile in specialty: 83 · MIPS quality, percentile: 72Part D claim volume, percentile in specialty: 39 · MIPS quality, percentile: 85Part D claim volume, percentile in specialty: 54 · MIPS quality, percentile: 85Part D claim volume, percentile in specialty: 96 · MIPS quality, percentile: 83Part D claim volume, percentile in specialty: 20 · MIPS quality, percentile: 7Part D claim volume, percentile in specialty: 59 · MIPS quality, percentile: 67Part D claim volume, percentile in specialty: 100 · MIPS quality, percentile: 0Part D claim volume, percentile in specialty: 65 · MIPS quality, percentile: 28Part D claim volume, percentile in specialty: 89 · MIPS quality, percentile: 20Part D claim volume, percentile in specialty: 78 · MIPS quality, percentile: 61Part D claim volume, percentile in specialty: 80 · MIPS quality, percentile: 4Part D claim volume, percentile in specialty: 48 · MIPS quality, percentile: 96Part D claim volume, percentile in specialty: 2 · MIPS quality, percentile: 72Part D claim volume, percentile in specialty: 46 · MIPS quality, percentile: 35Part D claim volume, percentile in specialty: 70 · MIPS quality, percentile: 85Part D claim volume, percentile in specialty: 43 · MIPS quality, percentile: 59Part D claim volume, percentile in specialty: 22 · MIPS quality, percentile: 17Part D claim volume, percentile in specialty: 52 · MIPS quality, percentile: 37Part D claim volume, percentile in specialty: 2 · MIPS quality, percentile: 65Part D claim volume, percentile in specialty: 85 · MIPS quality, percentile: 41Part D claim volume, percentile in specialty: 26 · MIPS quality, percentile: 2Part D claim volume, percentile in specialty: 50 · MIPS quality, percentile: 96Part D claim volume, percentile in specialty: 15 · MIPS quality, percentile: 13Part D claim volume, percentile in specialty: 9 · MIPS quality, percentile: 57Part D claim volume, percentile in specialty: 67 · MIPS quality, percentile: 54Part D claim volume, percentile in specialty: 91 · MIPS quality, percentile: 96Part D claim volume, percentile in specialty: 15 · MIPS quality, percentile: 28Part D claim volume, percentile in specialty: 98 · MIPS quality, percentile: 93Part D claim volume, percentile in specialty: 26 · MIPS quality, percentile: 70Part D claim volume, percentile in specialty: 72 · MIPS quality, percentile: 63Part D claim volume, percentile in specialty: 22 · MIPS quality, percentile: 72Part D claim volume, percentile in specialty: 74 · MIPS quality, percentile: 22Part D claim volume, percentile in specialty: 2 · MIPS quality, percentile: 50Part D claim volume, percentile in specialty: 0 · MIPS quality, percentile: 26Part D claim volume, percentile in specialty: 41 · MIPS quality, percentile: 48Part D claim volume, percentile in specialty: 61 · MIPS quality, percentile: 22Part D claim volume, percentile in specialty: 13 · MIPS quality, percentile: 80Part D claim volume, percentile in specialty: 57 · MIPS quality, percentile: 7Part D claim volume, percentile in specialty: 33 · MIPS quality, percentile: 52Part D claim volume, percentile in specialty: 87 · MIPS quality, percentile: 43Tuncay Delibasi, MD-Part D claim volume, percentile in specialty: 91 · MIPS quality, percentile: 38
Part D claim volume vs MIPS quality, by specialty percentile

Each dot is one clinical genetics (m.d.) physician peer from a representative sample of 46; the gold marker is Tuncay Delibasi, MD. Source: CMS Medicare Part D Prescriber data and the CMS Merit-based Incentive Payment System, 2023.

Board certification likely (heuristic, not verified)

Tuncay Delibasi, MD practices in an ABMS-board-eligible specialty and shows active CMS Medicare participation + MIPS quality reporting + 1 hospital affiliation - signals consistent with board-certified status. For verified board certification, see CertificationMatters.org (the official ABMS public lookup).

What does the federal data show about Tuncay Delibasi, MD?

Near national average

NPI registry status

Active

Issued 02/27/2020

NPI 1265066252

Primary specialty

Clinical Genetics (M.D.) Physician

Niche

825 US NPIs in this specialty

Medicare Part D claims

500 92% vs specialty avg

2023 prescription claims

Specialty avg: 261

MIPS final score

81.6/100 1.5 pts vs avg

Above neutral band

vs 83.1 national avg

Specialty distribution in New York

How Clinical Genetics (M.D.) Physician compares to other specialties among New York providers

New York providers

Largest specialties in New York (% of in-state providers)

Student in an Organized Health Care Education/Training Program - 7.8%Student in an Organized Health Care Education/Training Program7.8%Registered Nurse - 5.2%Registered Nurse5.2%Clinical Social Worker - 4.9%Clinical Social Worker4.9%Social Worker - 4.5%Social Worker4.5%Speech-Language Pathologist - 4.5%Speech-Language Pathologist4.5%Licensed Practical Nurse - 4.3%Licensed Practical Nurse4.3%Clinical Genetics (M.D.) Physician - 0%Clinical Genetics (M.D.) Physician0%
Largest specialties in New York (% of in-state providers)

Medicare quality performance, MIPS

Tuncay Delibasi, MD's 2023 MIPS final score plotted against the Clinical Genetics (M.D.) Physician national average

Near national average
MIPS Final Score
81.6/100
vs 83.1 national avg · 2023 performance year

MIPS final score (Clinical Genetics (M.D.) Physician) - 81.6/100 vs national avg 83.1

0%100%National avg83%81.6%
MIPS final score (Clinical Genetics (M.D.) Physician) - 81.6/100 vs national avg 83.1

The Merit-based Incentive Payment System (MIPS) scores providers 0–100 across four performance categories: Quality, Cost, Promoting Interoperability, and Improvement Activities, weighted under 42 CFR §414.1380. Reporting is voluntary for many small practices, so absence of a MIPS score is not a quality signal.

Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus continuous Maintenance of Certification cycles. Verify any individual provider's status through certificationmatters.org (ABMS) or osteopathic.org (AOA).

Tuncay Delibasi, MD appears in the CMS NPPES registry as a Clinical Genetics (M.D.) Physician provider holding MD credentials at 725 E. ADAMS STREET, Syracuse, NY, 13210, with a listed phone of (315) 464-5726. NPI 1265066252 was issued on 02/27/2020. Because NPPES data is self-reported by the provider and refreshed monthly, the address, phone, and specialty reflect what Delibasi most recently submitted to CMS rather than a vetted directory listing, which is why patients should always confirm the practice is still at this location before scheduling.

Medicare Part D records for calendar year 2023 show 500 prescription claims written by this provider, covering 153 Medicare beneficiaries and totaling roughly $292K in drug spend, split 40% brand-name and 49% generic by claim count. These figures capture only Medicare Part D, commercial insurance, Medicaid, and cash-pay prescriptions are not included, and any drug-beneficiary cell under 11 is suppressed by CMS for patient privacy. On the CMS Merit-based Incentive Payment System, this provider earned a Final Score of 81.6/100 for the 2023 performance year (Quality 73.9, Cost 52.8), compared with the national average of 83.1.

Clinical Genetics (M.D.) Physician is a narrow specialty nationwide, with 825 enrolled providers across 50 states and an average of 261 Part D claims per prescriber, so the context for interpreting these metrics differs meaningfully from a primary-care baseline. Important: PlainDoctor is a directory of publicly available government data, not medical advice, a malpractice database, or a quality rating. Inclusion here does not imply a recommendation, and absence of complaints or sanctions on this page does not mean none exist, always verify credentials through the NPPES NPI Registry, your state medical board, and the ABMS or AOA before making healthcare decisions.

Practice Address

725 E. ADAMS STREET
Syracuse, NY 13210

Provider Details

NPI 1265066252
Specialty Clinical Genetics (M.D.) Physician
Credentials MD
Gender Male
NPI Issued 02/27/2020

CMS Quality Score (MIPS)

Merit-based Incentive Payment System (MIPS) scores from CMS, 2023 performance year.

81.6325
Final Score
Avg: 83.1
73.8681
Quality
52.7956
Cost
100
Promoting Interoperability

Reporting: Group practice

Hospital and facility affiliations

Facilities where Tuncay Delibasi, MD bills Medicare from. Star ratings (1-5) are CMS Hospital Compare's "Hospital overall rating" - a composite of mortality, readmission, patient experience, safety, timely care, and efficient use of medical imaging measures. Source: CMS Care Compare.

Department OF Medicine Medical Serv Grp AT Suny Hlth Sci Ctr Syr IN
Syracuse, NY

Affiliations sourced from CMS Doctors and Clinicians National Downloadable File; hospital ratings from CMS Hospital General Information dataset (cross-referenced by facility name + state).

Industry payments received (2024) - CMS Open Payments transparency data

The federal Physician Payments Sunshine Act (part of the Affordable Care Act) requires drug and medical-device manufacturers + group purchasing organizations to publicly report payments and other transfers of value to physicians and teaching hospitals. The data below covers 2024 for Tuncay Delibasi, MD. Source: openpaymentsdata.cms.gov.

Total received

$134

Largest payer

Alexion Pharmaceuticals, Inc.

Most common payment type

Food and Beverage

Industry payments are not necessarily indicators of bias, they include research funding, consulting fees for evidence-based work, royalties for inventions, food at conferences, and similar items. The disclosure exists for transparency. Read our methodology for how we interpret this data.

License & disciplinary context - New York NYSBPMC 2023 annual report

Aggregate state board data only, NOT a determination of any individual provider's status. The figures below describe statewide disciplinary activity across all ~100K New York medical licensees in 2023 - they are NOT specific to Tuncay Delibasi, MD. To verify Tuncay Delibasi, MD's current license status, search the NYSBPMC public license lookup directly, or check the Federation of State Medical Boards (FSMB) verification service.

312
Total board actions, New York 2023
Across 302 cases
3.12
Actions per 1,000 licensees
New York statewide rate
probation
Most common action type
89 cases

NYSBPMC publishes annual disciplinary statistics as part of public-record reporting under each state's Administrative Procedure Act. See the full breakdown by action type and year on the New York disciplinary trends page. Cross-checked against FSMB U.S. Medical Regulatory Trends.

Brand vs generic prescribing mix · Above average

Tuncay Delibasi, MD - brand share 40.0%
Clinical Genetics (M.D.) Physician average

40% brand-name claims vs 49% generic, on 500 2023 Medicare Part D claims.

The federal Medicare Part D Generic Dispensing Rate national benchmark sits near 90% generic / 10% brand for primary-care prescribers, per CMS Office of the Actuary 2024 estimates. Higher brand share is common in specialty prescribing where generic equivalents are not available.

Medicare Part D Prescribing Data

CMS Medicare Part D prescriber-level data for calendar year 2023.

500
Total Claims
$292K
Total Drug Cost
153
Medicare Beneficiaries

Prescribing Breakdown

30-Day Fills
1,002
Total Day Supply
29,371
Brand vs Generic
40% brand / 49% generic
Brand Drug Cost
$268K
Generic Drug Cost
$10K

Patient Demographics

Average Patient Age
65.7 years
Avg HCC Risk Score
2.04
Gender Split
51% female / 49% male
Age Distribution
<65: 49, 65-74: 72, 75-84: N/A, 85+: N/A

Top Prescribed Drugs (Medicare Part D)

Top drugs by claim count for calendar year 2023. Based on Medicare Part D data only.

What Tuncay Delibasi, MD prescribes most

Top Medicare Part D drugs by claim count, 2023

claims
Source CMS Medicare Part D Prescriber Public Use File As of 2023
Drug Claims
Levothyroxine Sodium
59
Hydrocortisone
40
Ozempic
Semaglutide
25
Metformin Hcl
24
Trulicity
Dulaglutide
24
Metformin Hcl Er
Metformin Hcl
18
Jardiance
Empagliflozin
17
Novolog Flexpen
Insulin Aspart
17
Alendronate Sodium
16
Basaglar Kwikpen U-100
"Insulin Glargine
N/A

* Counts below 11 are suppressed by CMS for patient privacy. Generic names shown where available from CMS Part D data.

Clinical Genetics (M.D.) Physician Overview

How Tuncay Delibasi, MD fits within the Clinical Genetics (M.D.) Physician landscape nationally.

825
Clinical Genetics (M.D.) Physician Providers in US
50
States with Clinical Genetics (M.D.) Physician
261
Avg Claims per Provider

Tuncay Delibasi, MD's 500 claims are above the specialty average of 261.

Nearby Clinical Genetics (M.D.) Physician Providers in New York

Other clinicians with the same primary specialty enrolled in New York, drawn from the same CMS NPPES roster as Delibasi.

Compare Clinical Genetics (M.D.) Physician nationally: see state-by-state distribution →

Before you book an appointment

Use this federal record as your verification checklist, not as a recommendation.

  • Confirm the NPI record is current in the official CMS registry, providers update their own NPPES details, and moves can lag. Verify this NPI
  • Check the active license and any disciplinary history with the New York medical board, federal registration is not a license check. Credential verification guide
  • Weigh a second option: compare this provider with a nearby Clinical Genetics (M.D.) Physician peer on Medicare volume and prescribing patterns. Compare providers

Medicare Part D and MIPS figures describe practice patterns in federal programs only, they are not quality ratings, and PlainDoctor does not rate, rank, or recommend providers.

Frequently Asked Questions

What is Tuncay Delibasi, MD's specialty?
Tuncay Delibasi, MD specializes in Clinical Genetics (M.D.) Physician and practices in Syracuse, New York. Credentials: MD.
How much does Tuncay Delibasi, MD prescribe under Medicare Part D?
In 2023, Tuncay Delibasi, MD wrote 500 Medicare Part D claims totaling $292K in drug costs for 153 beneficiaries.
What is Tuncay Delibasi, MD's Medicare quality score?
Tuncay Delibasi, MD has a CMS MIPS Final Score of 81.6/100 (Quality: 73.9, Cost: 52.8). The national average MIPS Final Score is 83.1. Source: CMS Merit-based Incentive Payment System (MIPS) 2023.
Where is Tuncay Delibasi, MD located?
Tuncay Delibasi, MD is located at 725 E. ADAMS STREET, Syracuse, NY, 13210. Phone: (315) 464-5726.
What is Tuncay Delibasi, MD's NPI number?
Tuncay Delibasi, MD's National Provider Identifier (NPI) is 1265066252, issued on 02/27/2020.
Does Tuncay Delibasi, MD prescribe more brand-name or generic drugs?
Tuncay Delibasi, MD's prescribing is 40% brand-name and 49% generic drugs by claim count, with $268K in brand drug costs.
How many Clinical Genetics (M.D.) Physician providers are there in the US?
There are 825 Clinical Genetics (M.D.) Physician providers across 50 states in the US. The average Clinical Genetics (M.D.) Physician provider writes 261 Medicare Part D claims per year.
What drugs does Tuncay Delibasi, MD prescribe most often?
Based on 2023 Medicare Part D data, Tuncay Delibasi, MD's most frequently prescribed drugs include Levothyroxine Sodium, Hydrocortisone, Ozempic. This reflects Medicare Part D prescriptions only and does not include commercial insurance or other payer types.
Does Tuncay Delibasi, MD accept Medicare?
Tuncay Delibasi, MD appears in CMS Medicare data with 500 Part D claims and 153 Medicare beneficiaries in 2023. Contact the provider's office directly to confirm current Medicare enrollment and accepted plans.
How can I verify Tuncay Delibasi, MD's credentials?
Tuncay Delibasi, MD's NPI is 1265066252 with credentials MD. You can verify this through the NPPES NPI Registry, check state medical board records, and confirm board certification through the ABMS or AOA.

Data Sources

Provider Directory
CMS National Plan and Provider Enumeration System (NPPES), download.cms.gov/nppes, updated monthly. Contains NPI, specialty, credentials, and practice location.
Specialty Classification
NUCC Health Care Provider Taxonomy (nucc.org), the industry standard for classifying provider specialties in Medicare and Medicaid billing.
Prescribing Data
CMS Medicare Part D Prescriber Public Use File (2023). Includes claims, drug costs, beneficiaries, and opioid prescribing rates.
Quality Performance
CMS Merit-based Incentive Payment System (MIPS) - 2023 performance year.
Limitations
Provider data is self-reported to CMS. Prescribing data reflects Medicare Part D only and does not include commercial insurance, Medicaid, or cash prescriptions. Claims below 11 beneficiaries are suppressed by CMS for privacy.

See our complete data methodology for details on how we collect and process government data.

Data as of April 2026 (NPPES) / 2023 (Medicare Part D). Source: Centers for Medicare & Medicaid Services (CMS).

Disclaimer: Data from CMS NPPES and Medicare Part D. PlainDoctor does not rate or rank providers. Provider information is self-reported and may not be current. Always verify information directly with the provider. About · Methodology

Compiled from official public sources by the PlainDoctor editorial team.